Lab-designed chimeric protein shows beneficial effects in animal models of Alzheimer’s disease

A research team at the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has developed a new protein capable of improving memory and reducing tau protein levels in animal models of Alzheimer’s disease. The new compound—HEBE, generated by fusing three proteins—represents a new approach in the search for new strategies to tackle the disease…
Read More